| scholarly article | Q13442814 |
| P50 | author | Dhruvan Patel | Q89390916 |
| P2093 | author name string | Yu-Xiao Yang | |
| Nabeel Khan | |||
| Yash Shah | |||
| Chinmay Trivedi | |||
| P2860 | cites work | Dual use of Medicare and the Veterans Health Administration: are there adverse health outcomes? | Q33259845 |
| Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee | Q33523446 | ||
| Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease--do we have reliable markers? | Q33930756 | ||
| Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study | Q34425918 | ||
| Laboratory markers in IBD: useful, magic, or unnecessary toys? | Q36394876 | ||
| Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies | Q37126870 | ||
| Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis | Q37853364 | ||
| Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids | Q37955509 | ||
| Prediction of clinical and endoscopic responses to anti-tumor necrosis factor-α antibodies in ulcerative colitis | Q38906748 | ||
| Corticosteroid Use in a Prospective, Community-Based Cohort of Newly Diagnosed Inflammatory Bowel Disease Patients. | Q38925309 | ||
| Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients | Q40382305 | ||
| Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology | Q40390478 | ||
| Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis | Q40609049 | ||
| Assessment of severity in colitis: a preliminary study | Q41988487 | ||
| Management of severe hemorrhage in ulcerative colitis | Q42074954 | ||
| Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort | Q44024340 | ||
| Prevalence of corticosteroids use and disease course after initial steroid exposure in ulcerative colitis | Q44556974 | ||
| Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort | Q44646651 | ||
| Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). | Q44791207 | ||
| Severe ulcerative colitis: prospective study of parameters determining outcome | Q45105361 | ||
| Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life | Q48174168 | ||
| Early corticosteroids requirement after the diagnosis of ulcerative colitis diagnosis can predict a more severe long-term course of the disease - a nationwide study of 1035 patients | Q48267292 | ||
| Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. | Q50795640 | ||
| Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. | Q54563945 | ||
| Effects of smoking on the presentation and clinical course of inflammatory bowel disease | Q61866497 | ||
| The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort | Q64461015 | ||
| Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study | Q73503133 | ||
| The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study | Q74315857 | ||
| Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study) | Q79802677 | ||
| Predictors of Crohn's disease | Q82792350 | ||
| Predictors of severe Crohn's disease | Q82984823 | ||
| The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII) | Q93929906 | ||
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8008-8016 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Albumin as a prognostic marker for ulcerative colitis | |
| P478 | volume | 23 |
Search more.